SEC Form 4 · accession 0001225208-19-001863
PFIZER INC · PFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank A Damelio
Officer — Executive Vice President
Period of report
Feb 4, 2019
Accepted (ET)
Feb 6, 2019 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000078003
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 4, 2019 | I | 5,182 | $42.44 | D | 0 | I | By Rule 16b-3 Plan |
| Common Stock | holding | — | — | — | 337,391 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom Stock Units SSPF3,F2,F4 | — | Feb 4, 2019 | I | 42,690 | D | — | — | Common Stock | 42,690 | 0 | D |
Explanation of responses
- F1This transaction constitutes an intra-plan transfer involving the Pfizer stock fund under the Company's Qualified Savings Plan.
- F2Each unit represents one phantom share of common stock.
- F3This transaction constitutes an intra-plan transfer involving the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan.
- F4These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.